A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occupancy and Food Effect

Clinical trial NCT05486195 · COMPLETED

Trial details

NCT number: NCT05486195
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cognitive Disorders

Start date: 2019-03-14
Primary completion: 2019-07-29
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.